工程化免疫:CAR-T 细胞治疗的当前进展与未来方向 Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy. PubMed 2026/01/16 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD19靶点:BCMA技术:CAR-T技术:mRNA血液系统恶性肿瘤实体瘤